"These products are not offered in countries where valid patents exist. However, final responsibility with respect to third party's patent rights in a specific country lies exclusively with the user."
 

ACTIVE PHARMACEUTICAL INGREDIENTS

  • Atenolol USP
(US DMF No. 024024)
     
  • Ciprofloxacin Hydrochloride USP
(U.S.DMF No. 17786)
     
  • Cilnidipine
     
  • Diclofenac Acid
(U.S.DMF No. 15366)
     
  • Diclofenac Diethylamine BP
(US DMF No. 19020 & Spain DMF No. DD-708 / 01)
     
  • Diclofenac Potassium BP/EP/USP
(Plant approved by FDA, U.S.A. - U.S.DMF No. 15074)
     
  • Diclofenac Sodium BP/EP/USP
(U.S. DMF No 12469) (Spain DMF No. DS-092/978) (Canadian DMF No. 2005-055)
(Certicate of Suitability No. R1-CEP-1997-041-REV 03) .
     
  • Diclofenac Sodium BP/EP/USP also Injectable Grade
     
  • Gadopentatic Acid
     
  • Nifedipine BP/EP/USP
(US DMF No. 16730)
(Certificate of Suitability No. RO-CEP 2000-096- REV. 02).
     
 
 
Products under development

• Cetrazine HCL

• Ofloxacin USP



Brands | API | Formulations



 
Copyright © 2005 J. B. Chemicals & Pharmaceuticals Ltd. All rights reserved.